Company intelligence / Profile preview
Pelagos Pharmaceuticals
Houston, Texas, United Statespelagospharma.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Preclinical
01
Overview
No published clinical results. The company operates in stealth mode and focuses on developing next-generation inflammasome therapeutics and drugs that mimic the beneficial effects of acute aerobic exercise through metabolic/mitochondrial pathway activation.
- Therapeutic areas
- Metabolic DisordersCardiovascular
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Mercury Fund investor relationship noted, but no major pharma partnerships disclosed yet
Beyond the preview
Go deeper on Pelagos Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pelagos Pharmaceuticals.